Interestingly, MPP2 mislocalization has been observed in two non-small-cell lung cancer (NSCLC) cell lines, NCI-H596 and SK-LU-1, characterized by a loss of CADM1 and 4.1B expression [53]. This evidence concerns the gene CADM1 and non-small cell lung carcinoma.